1.48
60 Degrees Pharmaceuticals Inc stock is traded at $1.48, with a volume of 75,229.
It is up +1.37% in the last 24 hours and up +10.45% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.46
Open:
$1.5
24h Volume:
75,229
Relative Volume:
0.13
Market Cap:
$6.07M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1484
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
+13.85%
1M Performance:
+10.45%
6M Performance:
-6.92%
1Y Performance:
-78.39%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SXTP
60 Degrees Pharmaceuticals Inc
|
1.48 | 5.83M | 502.40K | -7.91M | -4.32M | -9.972 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
How to escape a deep drawdown in 60 Degrees Pharmaceuticals Inc.Trade Entry Summary & Entry Point Strategy Guides - Newser
How institutional ownership impacts 60 Degrees Pharmaceuticals Inc. Equity Warrant stockInflation Watch & Fast Entry Momentum Alerts - Newser
Using data tools to time your 60 Degrees Pharmaceuticals Inc. Equity Warrant exitQuarterly Profit Review & Fast Exit and Entry Strategy Plans - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc. Equity WarrantTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference - The Manila Times
60 Degrees Pharma updates conference presentation webcast link, rescheduled for September 9. - AInvest
60 Degrees Pharmaceuticals Presents at H.C. Wainwright 27th Annual Global Investment Conference on September 9 - AInvest
Vector-borne Disease Biotech 60 Degrees Pharmaceuticals Sets New Time for H.C. Wainwright Conference - Stock Titan
Can volume confirm reversal in 60 Degrees Pharmaceuticals Inc. Equity WarrantWeekly Gains Summary & Technical Analysis for Trade Confirmation - Newser
Custom watchlist performance reports with 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Market Outlook & Weekly Top Gainers Alerts - Newser
How to build a custom watchlist for 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Big Picture & Risk Managed Investment Entry Signals - Newser
Using data tools to time your 60 Degrees Pharmaceuticals Inc. exitTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Regression analysis insights on 60 Degrees Pharmaceuticals Inc. performanceLayoff News & Daily Volume Surge Trade Alerts - Newser
Is 60 Degrees Pharmaceuticals Inc. meeting your algorithmic filter criteriaTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Forecasting 60 Degrees Pharmaceuticals Inc. price range with options dataJuly 2025 Weekly Recap & Community Consensus Stock Picks - Newser
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant fit your quant trading modelEarnings Risk Report & High Yield Stock Recommendations - Newser
Can 60 Degrees Pharmaceuticals Inc. maintain sales growthJuly 2025 Spike Watch & Smart Allocation Stock Reports - khodrobank.com
What’s the outlook for 60 Degrees Pharmaceuticals Inc. Equity Warrant’s sectorTrade Analysis Report & Low Volatility Stock Recommendations - khodrobank.com
Applying chart zones and confluence areas to 60 Degrees Pharmaceuticals Inc.2025 Support & Resistance & Daily Risk Controlled Trade Plans - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock ready for a breakoutQuarterly Profit Summary & Weekly Top Performers Watchlists - Newser
What institutional flow reveals about 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from government policy2025 Analyst Calls & Technical Pattern Based Signals - khodrobank.com
Is 60 Degrees Pharmaceuticals Inc. a cyclical or defensive stock2025 Technical Overview & Expert Approved Momentum Ideas - khodrobank.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from rising consumer demandJuly 2025 Breakouts & Verified Momentum Watchlists - khodrobank.com
Does 60 Degrees Pharmaceuticals Inc. Equity Warrant offer margin of safetyQuarterly Risk Review & Technical Analysis for Trade Confirmation - khodrobank.com
Building trade automation scripts for 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Combining price and volume data for 60 Degrees Pharmaceuticals Inc.July 2025 Reactions & Free Reliable Trade Execution Plans - Newser
Multi asset correlation models including 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Is 60 Degrees Pharmaceuticals Inc. forming a double bottomTrade Risk Summary & Technical Pattern Recognition Alerts - khodrobank.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock undervalued right now2025 Trading Volume Trends & Weekly Stock Performance Updates - khodrobank.com
Will 60 Degrees Pharmaceuticals Inc. benefit from rate cutsMarket Weekly Review & Weekly Chart Analysis and Guides - khodrobank.com
Visual analytics tools that track 60 Degrees Pharmaceuticals Inc. Equity Warrant performance2025 Market WrapUp & Free Technical Confirmation Trade Alerts - Newser
Sentiment analysis tools applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantShare Buyback & Growth Focused Stock Reports - Newser
What are 60 Degrees Pharmaceuticals Inc.’s earnings expectations2025 Growth vs Value & AI Powered Market Entry Ideas - khodrobank.com
Can 60 Degrees Pharmaceuticals Inc. be recession proofExit Point & Technical Pattern Alert System - khodrobank.com
Can a trend reversal in 60 Degrees Pharmaceuticals Inc. lead to recovery2025 AllTime Highs & Daily Profit Focused Screening - Newser
Market reaction to 60 Degrees Pharmaceuticals Inc. Equity Warrant’s recent newsQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser
Heatmap analysis for 60 Degrees Pharmaceuticals Inc. Equity Warrant and competitorsJuly 2025 Update & AI Driven Price Predictions - Newser
Intraday pattern recognizer results for 60 Degrees Pharmaceuticals Inc.Weekly Trade Recap & Weekly Hot Stock Watchlists - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Has 60 Degrees Pharmaceuticals Inc. Equity Warrant found a price floorStock Surge & Weekly High Return Stock Opportunities - Newser
Does 60 Degrees Pharmaceuticals Inc. qualify in momentum factor screeningMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant’s volatility index tracking explainedEarnings Miss & Breakout Confirmation Alerts - Newser
Tools to assess 60 Degrees Pharmaceuticals Inc.’s risk profileInflation Watch & Reliable Intraday Trade Plans - Newser
Does 60 Degrees Pharmaceuticals Inc. fit your quant trading modelWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
What the charts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant todayJuly 2025 Update & Consistent Return Strategy Ideas - Newser
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):